microrna
mir
short
regulatori
rna
molecul
inhibit
translat
target
messeng
rna
mrna
base
sequenc
complementar
biogenesi
mir
involv
transcript
mir
host
gene
follow
seri
posttranscript
process
step
within
nucleu
cytoplasm
result
approxim
matur
mir
load
rnainduc
silenc
complex
risc
capabl
target
repress
interact
multipl
target
mir
particip
numer
cellular
process
rang
embryon
develop
carcinogenesi
immun
classic
exampl
multifunct
mir
play
essenti
role
hematopoiet
develop
inflammatori
respons
autoimmun
cancer
progress
context
immun
upregul
cell
b
cell
macrophag
dendrit
cell
dc
upon
cellular
activ
contribut
effector
respons
regul
target
gene
recent
studi
shown
cellspecif
express
necessari
optim
antitumor
immun
variou
experiment
model
detail
understand
cellexpress
impact
tumor
microenviron
tme
lack
impact
prognosi
human
solid
tumor
remain
elucid
tme
compos
sever
differ
immun
cell
type
protumorigen
antitumorigen
properti
play
activ
role
cancer
develop
progress
understand
dynam
tme
essenti
devis
effect
new
cancer
therapeut
predict
patient
like
respond
immunotherapi
advent
flow
cytometri
enabl
character
cell
infiltr
tumor
use
cellspecif
antibodi
unabl
captur
true
heterogen
recent
emerg
import
promot
antitumor
immun
function
lymphocyt
howev
impact
cellexpress
immun
cell
dynam
solid
tumor
remain
unclear
present
studi
use
singlecel
rna
sequenc
defin
immun
cell
popul
differ
time
point
within
murin
melanoma
tumor
grow
either
wildtyp
cell
condit
knockout
tcko
mice
requir
optim
cell
activ
reinforc
cell
respons
expens
infiltr
myeloid
cell
myeloid
cell
tumor
grow
tcko
mice
defin
increas
wound
heal
gene
decreas
gene
signatur
final
found
express
predict
favor
outcom
human
melanoma
patient
associ
strong
immun
signatur
moreov
gene
express
analysi
cancer
genom
atla
tcga
data
reveal
express
also
correl
immuneenrich
subtyp
human
solid
tumor
togeth
studi
provid
unpreced
analysi
cell
type
gene
express
signatur
immun
cell
within
experiment
melanoma
tumor
elucid
role
coordin
antitumor
immun
respons
mammalian
tumor
tme
activ
state
infiltr
immun
cell
emerg
singlecel
rna
sequenc
scseq
technolog
provid
power
altern
investig
characterist
tme
studi
antitumor
immun
respons
unpreced
resolut
recent
studi
employ
scseq
technolog
dissect
molecular
featur
tme
preclin
clinic
model
unveil
common
contextdepend
aspect
antitumor
immun
expand
util
scseq
new
cancer
model
essenti
obtain
complet
understand
immun
system
respond
develop
tumor
eventu
goal
reveal
pathway
leverag
therapeut
purpos
studi
use
scseq
character
murin
melanoma
immun
microenviron
presenc
absenc
cellspecif
two
differ
time
point
support
previou
result
found
essenti
antitumor
immun
respons
evidenc
faster
tumor
growth
cell
condit
mice
tcko
scseq
demonstr
complex
landscap
tumorinfiltr
immun
cell
includ
multipl
popul
cell
natur
killer
nk
cell
neutrophil
dc
macrophag
defin
distinct
activ
state
timeand
genotypedepend
manner
cellspecif
express
critic
cell
effector
respons
also
program
sever
myeloid
cell
popul
tme
interestingli
analysi
cancer
genom
atla
tcga
data
reveal
express
correl
improv
clinic
outcom
human
melanoma
defin
immuneenrich
tumor
subtyp
furthermor
express
mark
immuneenrich
solid
tumor
subpopul
across
tcga
solid
cancer
cohort
posit
correl
multipl
immun
signatur
paramet
also
found
express
associ
improv
clinic
outcom
especi
cancer
high
mutat
burden
melanoma
lung
cancer
taken
togeth
result
describ
critic
role
cellspecif
shape
tme
effect
antitumor
immun
find
also
delin
characterist
kinet
antitumor
immun
murin
melanoma
first
time
knowledg
suggest
antitumor
immun
respons
defin
express
human
cancer
scseq
reveal
immun
cell
divers
within
tme
melanoma
tme
compos
varieti
immun
cell
proand
antitumorigen
function
previous
shown
critic
mediat
antitumor
immun
mice
effect
cellspecif
express
dynam
tme
unknown
analyz
composit
tme
phenotyp
tumorinfiltr
immun
cell
employ
genom
scseq
technolog
murin
melanoma
cell
express
chicken
ovalbumin
ova
model
antigen
inject
subcutan
wildtyp
wt
tcko
mice
nine
day
tumor
inject
live
immun
cell
sort
pool
tumor
n
per
time
point
via
flow
cytometri
subject
scseq
figur
supplement
figur
supplement
materi
avail
onlin
articl
http
consist
previou
find
observ
major
differ
tumor
growth
day
wherea
day
tcko
mice
exhibit
higher
tumor
burden
figur
suggest
lack
product
antitumor
immun
mice
cellspecif
express
lost
aggreg
data
individu
cell
cellswt
tcko
cellswt
tcko
perform
unsupervis
cluster
analysi
base
similar
gene
express
signatur
use
seurat
singlecel
genom
r
packag
analysi
reveal
distinct
cell
cluster
repres
lymphoid
myeloid
lineag
figur
c
supplement
figur
due
high
dimension
data
overlap
express
marker
gene
identifi
biolog
natur
cell
cluster
scseq
experi
challeng
task
survey
express
known
marker
aid
descript
broad
immun
cell
popul
supplement
figur
granular
analysi
cell
cluster
requir
examin
multipl
gene
simultan
assist
identif
cell
cluster
develop
algorithm
compar
gene
express
signatur
scseq
cell
cluster
publicli
avail
immunolog
genom
project
immgen
databas
see
method
immgen
databas
host
microarray
rna
sequenc
rnaseq
data
purifi
immun
cell
subset
variou
experiment
condit
algorithm
calcul
aggreg
ident
score
scseq
cell
cluster
measur
molecular
similar
immgen
subset
supplement
figur
algorithm
certain
cell
cluster
includ
plasmacytoid
dc
pdc
activ
naiv
cell
nk
cell
langerhan
cell
confid
identifi
supplement
figur
cell
cluster
algorithm
could
make
clear
call
macrophag
neutrophil
popul
resort
differenti
express
analysi
cluster
identifi
distinguish
marker
combin
approach
among
distinct
cluster
data
set
identifi
cell
subset
naiv
activ
activ
cycl
cell
subset
neutrophilgranulocyt
subset
macrophag
subset
dc
subset
langerhan
plasmacytoid
subset
nk
cell
monocyt
figur
supplement
figur
differenti
express
analysi
cluster
reveal
distinct
gene
signatur
support
uniqu
molecular
characterist
cluster
figur
among
cluster
host
gene
express
detect
activ
cell
nk
cell
langerhan
dc
figur
verifi
algorithmassist
identif
cell
cluster
examin
express
known
cellular
marker
data
set
expect
express
marker
correspond
respect
ident
cluster
figur
surprisingli
consider
overlap
observ
gene
express
profil
close
relat
cell
cluster
result
underscor
need
multidimension
analyt
approach
character
cellular
heterogen
tme
suggest
lymphoid
myeloid
cell
subpopul
tme
exhibit
distinct
molecular
characterist
upon
confid
identifi
cell
cluster
analyz
differ
wt
tcko
tumorinfiltr
immun
cell
day
tumor
inject
data
time
point
genotyp
plot
side
side
timeand
genotypedepend
dynam
within
tme
start
emerg
figur
earli
day
activ
cell
cluster
enrich
wt
sampl
compar
tcko
counterpart
howev
day
differ
much
pronounc
figur
g
h
later
time
point
activ
cell
cluster
present
tcko
mice
repres
lower
frequenc
figur
gray
arrow
distinct
popul
activ
cell
character
express
cell
cycl
gene
henc
name
activ
cycl
cluster
also
enrich
wt
mice
day
interestingli
activ
cycl
cell
cluster
pronounc
wt
mice
day
compar
wt
mice
day
figur
red
arrow
nk
cell
dc
subset
also
enrich
wt
sampl
day
although
look
similar
wt
tcko
sampl
day
figur
g
h
contrast
sever
myeloid
popul
expand
tumor
grown
tcko
mice
day
true
neutrophil
subset
monocyt
data
set
figur
g
h
level
macrophag
pdc
also
elev
albeit
lower
extent
tcko
tumor
day
taken
togeth
data
suggest
antitumor
immun
cell
expand
within
tme
day
tumor
growth
wt
mice
wherea
tcko
mice
tme
shift
toward
protumorigen
state
absenc
product
cell
respons
cellintrins
essenti
antitumor
immun
activ
previous
shown
import
optim
cell
antitumor
respons
molecular
characterist
defici
cell
subset
tme
studi
tempor
next
focus
analysi
infiltr
cell
investig
effect
loss
cell
activ
phenotyp
complement
find
cluster
level
first
subset
singlecel
gene
express
data
base
concomit
express
broad
marker
cytotox
activ
cell
gray
arrow
activ
cycl
cell
red
arrow
naiv
cell
yellow
arrowhead
pdc
dagger
neutrophil
unfil
circl
neutrophil
fill
circl
monocyt
unfil
squar
fill
squar
cluster
indic
h
frequenc
cell
cluster
wt
tcko
tumor
microenviron
day
cell
expect
loss
result
lower
frequenc
intratumor
cell
day
figur
interestingli
overal
frequenc
cell
increas
tcko
mice
day
day
increas
attenu
compar
increas
observ
wt
mice
analyz
ifng
express
within
cell
observ
approxim
induct
wt
mice
day
day
cell
tcko
mice
lack
abil
induc
valid
find
scseq
use
multicolor
flow
cytometri
observ
lower
percentag
cell
diminish
product
cell
tumor
grown
tcko
versu
wt
mice
figur
proceed
analyz
express
level
known
cell
activ
marker
effector
molecul
within
subset
lselectin
encod
sell
gene
commonli
use
marker
distinguish
activ
hi
lo
naiv
lo
hi
cell
subset
support
find
cluster
analysi
observ
higher
level
lower
level
wt
cell
suggest
activ
phenotyp
figur
day
day
observ
higher
express
level
ifng
granzym
b
gzmb
wt
cell
compar
tcko
counterpart
averag
figur
gzmb
critic
mediat
cell
cytotox
tumor
pathogen
elev
express
activ
marker
gene
encod
encod
observ
wt
cell
particularli
day
tumor
progress
find
suggest
intratumor
cell
compart
wt
mice
compos
activ
cell
compar
tcko
mice
support
interpret
gene
set
enrich
analysi
gsea
intratumor
cell
wt
tcko
mice
day
reveal
enrich
cellular
prolifer
effector
cell
gene
express
signatur
wt
sampl
figur
limit
analysi
activ
cell
cluster
identifi
figur
observ
higher
express
frequenc
multipl
activ
marker
gene
includ
ifng
gzmb
figur
supplement
figur
taken
togeth
find
suggest
antitumor
cell
respons
evolv
time
cellintrins
express
essenti
cell
infiltr
tumor
reach
activ
state
lastli
want
examin
express
level
target
singlecel
resolut
analysi
mir
target
via
commonli
use
method
qpcr
bulk
rnaseq
western
blot
provid
overal
measur
mix
cell
popul
delin
effect
mir
individu
cell
studi
heterogen
cellular
respons
mir
possibl
method
instanc
upon
experiment
manipul
mir
target
gene
express
may
alter
uniformli
across
popul
certain
extent
could
alter
small
subset
cell
much
greater
level
result
overal
observ
chang
context
scseq
novel
tool
capabl
examin
express
mir
target
individu
cell
level
sinc
express
induc
cell
upon
activ
flox
model
delet
cell
investig
express
level
target
activ
cell
cluster
within
data
set
found
gene
ubiquit
express
variabl
express
across
data
set
address
issu
show
sidebysid
result
wt
sampl
differ
number
cell
scale
frequenc
cell
rel
abund
frequenc
cell
express
gene
interest
normal
rel
frequenc
cell
express
gene
calcul
base
normal
valu
expect
rel
number
cell
express
target
gene
higher
tcko
mice
time
point
figur
f
g
interestingli
differ
wt
tcko
cell
consist
across
spectrum
target
gene
express
suggest
broad
derepress
target
oppos
high
level
upregul
narrow
subset
cell
upon
delet
result
indic
express
target
gene
similarli
affect
across
singl
cell
clone
support
idea
express
uniformli
modifi
target
gene
within
cell
popul
experiment
model
cell
control
phenotyp
tumorinfiltr
myeloid
cell
upon
activ
cell
produc
sever
molecul
interact
myeloid
cell
regul
function
next
proceed
analyz
myeloid
cell
tumor
grown
wt
tcko
mice
first
examin
frequenc
cell
express
itgam
encod
encod
marker
measur
macrophag
tme
observ
obviou
differ
day
wt
show
elev
level
cell
tumor
wt
mice
higher
level
product
cell
twotail
test
use
statist
comparison
p
ns
p
c
express
level
cell
activ
marker
effector
gene
within
cell
shown
sell
encod
respect
plot
dot
repres
singl
cell
normal
express
valu
use
random
nois
ad
show
distribut
data
point
box
plot
show
interquartil
rang
median
valu
bold
horizont
bar
averag
express
valu
per
sampl
indic
red
point
wilcoxon
test
use
statist
comparison
p
p
p
p
ns
p
gene
set
enrich
analysi
gsea
cell
scseq
data
day
normal
enrich
score
ne
adjust
p
valu
shown
wt
cell
enrich
cell
cycl
gene
gene
upregul
effector
cell
gene
set
deriv
msigdb
e
analysi
activ
marker
within
activ
cell
cluster
defin
figur
show
robust
activ
phenotyp
wt
cell
f
analysi
target
gene
express
activ
cell
cluster
day
x
axi
stack
histogram
indic
normal
express
valu
target
gene
axi
indic
scale
frequenc
cell
account
differ
cell
number
per
sampl
frequenc
cell
express
indic
gene
scale
dash
line
indic
averag
express
valu
group
g
analysi
target
activ
cell
cluster
day
data
scale
similarli
panel
f
tcko
mice
day
tcko
mice
higher
frequenc
macrophag
compar
wt
mice
figur
interestingli
level
intratumor
macrophag
wt
mice
decreas
day
day
limit
analysi
surrog
gener
myeloid
cell
phenotyp
also
observ
higher
proport
tcko
mice
day
figur
flow
cytometr
analysi
tumorinfiltr
immun
cell
valid
observ
scseq
show
higher
frequenc
macrophag
myeloidderiv
suppressor
cell
mdsc
tcko
mice
day
figur
macrophag
tumor
grown
tcko
mice
express
higher
level
arginas
chitinaselik
also
known
commonli
use
marker
defin
protumorigen
state
figur
chang
express
level
valid
qpcr
supplement
figur
princip
compon
analysi
pca
macrophag
cluster
defin
figur
use
consist
express
immuneassoci
gene
defin
distinct
molecular
phenotyp
macrophag
tcko
mice
day
suggest
myeloid
compart
tme
undergo
phenotyp
evolut
time
figur
global
gene
express
signatur
macrophag
examin
gene
found
enrich
wt
mice
wherea
tcko
macrophag
enrich
woundheal
phenotyp
day
figur
supplement
figur
interestingli
cell
wt
mice
compar
time
point
observ
signific
enrich
gene
day
supplement
figur
support
interpret
antitumor
immun
respons
enhanc
day
addit
enrich
signatur
evid
sever
cell
type
wt
tumor
microenviron
day
includ
neutrophil
variou
dc
popul
suggest
secret
cell
interact
multipl
cell
type
tme
supplement
figur
complement
observ
macrophag
also
found
elev
within
tme
tcko
mice
figur
furthermor
marker
mdsc
mice
human
express
higher
frequenc
mice
figur
suggest
greater
portion
develop
mdsclike
phenotyp
express
lost
cell
find
demonstr
tumorinfiltr
immun
cell
wt
mice
function
togeth
mount
potent
antitumor
immun
respons
day
tumor
growth
show
loss
cell
reprogram
tme
toward
protumorigen
state
affect
multipl
myeloid
cell
subset
express
defin
immuneenrich
subtyp
human
melanoma
addit
role
immun
mir
known
import
determin
tumorigenesi
specif
shown
protumorigen
antitumorigen
properti
depend
tumor
context
tumor
cellintrins
manner
express
tumor
cell
infiltr
immun
cell
exert
differ
function
role
determin
tumor
prognosi
human
cancer
remain
elucid
follow
find
murin
melanoma
model
first
focus
mir
sequenc
mirseq
data
human
skin
cutan
melanoma
skcm
tcga
databas
assess
whether
express
correl
surviv
outcom
clinic
paramet
express
level
matur
across
skcm
patient
group
categor
top
bottom
third
kaplanmei
surviv
curv
plot
group
patient
analysi
show
higher
express
significantli
mark
subpopul
patient
favor
clinic
outcom
skcm
figur
turn
rnaseq
data
patient
investig
differenti
gene
express
group
sever
hundr
gene
found
differenti
regul
melanoma
patient
gene
upregul
gene
downregul
adjust
p
valu
figur
ptprc
gene
encod
panleukocyt
marker
found
among
significantli
upregul
gene
suggest
immuneenrich
subtyp
cohort
figur
b
c
interestingli
sever
gene
associ
cell
includ
cell
receptor
complex
signal
transduc
lck
lat
coreceptor
effector
molecul
ifng
gzmb
also
upregul
suggest
presenc
activ
cell
tme
figur
major
gene
exhibit
upregul
tumor
figur
b
c
landmark
studi
publish
tcga
consortium
describ
multipl
molecular
clinic
characterist
skcm
studi
author
classifi
melanoma
sampl
group
immunerich
keratinrich
microphthalmiaassoci
transcript
factorlow
mitflow
subclass
depend
express
immuneand
tumorspecif
marker
next
want
investig
clinic
classif
immuneassoci
gene
express
profil
tumor
subgroup
skcm
interestingli
subpopul
skcm
tumor
figur
use
consist
express
immuneassoci
gene
gene
select
base
mous
immun
process
go
annot
filter
gene
averag
express
count
less
per
cell
macrophag
tcko
mice
day
uniqu
gene
express
profil
evidenc
spatial
separ
pca
plot
e
analysi
gene
set
enrich
macrophag
day
normal
enrich
score
ne
adjust
p
valu
shown
wt
macrophag
enrich
pathway
gene
wherea
macrophag
tcko
mice
upregul
gene
relat
wound
heal
pathway
gene
set
deriv
msigdb
f
express
level
mdscassoci
gene
within
scseq
dataset
suggest
mdsclike
phenotyp
cell
tcko
mice
graph
prepar
similarli
panel
c
p
p
p
ns
p
wilcoxon
test
express
higher
level
sever
immunerel
gene
includ
gener
immun
cell
marker
costimulatori
coinhibitori
receptor
effector
molecul
figur
note
mediat
protumorigen
phenotyp
express
slightli
higher
level
group
strikingli
subpopul
patient
correspond
immunerich
melanoma
subtyp
describ
tcga
studi
figur
green
column
annot
find
support
higher
lymphocyt
infiltr
score
tumor
figur
dark
red
column
annot
describ
tcga
studi
interestingli
examin
relationship
express
level
variou
immun
gene
note
strong
nearli
linear
posit
correl
suggest
express
continuum
overlap
immun
signatur
tme
figur
supplement
figur
human
melanoma
tumor
highli
infiltr
lymphocyt
upon
observ
posit
correl
immun
gene
express
next
perform
gsea
versu
patient
cohort
character
activ
signal
network
agreement
higher
ifng
transcript
level
observ
enrich
gene
signatur
tumor
figur
furthermor
melanoma
subset
significantli
enrich
inflammatori
pathway
includ
tumor
necrosi
factor
tnfa
ifna
interleukin
signal
supplement
figur
contrast
melanoma
subset
character
enrich
prolif
pathway
indic
higher
represent
transcript
tumor
origin
rnaseq
data
supplement
figur
note
subset
also
exhibit
enrich
gene
regul
myc
oncogen
shown
neg
regul
antitumor
immun
respons
supplement
figur
understand
cancer
patient
respond
immunotherapi
import
clinic
challeng
recent
studi
examin
gene
express
profil
tcga
tumor
defin
immun
signatur
score
predict
respons
variou
form
immunotherapi
studi
score
found
posit
correl
gene
signatur
tumor
lymphocyt
infiltr
sinc
express
also
mark
immunerich
subtyp
human
melanoma
next
want
determin
associ
score
express
level
analysi
reveal
express
strikingli
correl
score
human
melanoma
figur
importantli
highest
lowest
tcga
melanoma
sampl
examin
histolog
brisk
lymphocyt
infiltr
evid
subset
figur
c
taken
togeth
find
support
role
defin
immunerich
subtyp
human
melanoma
suggest
intratumor
express
may
import
clinic
implic
express
posit
correl
immun
enrich
varieti
distinct
human
solid
tumor
tcga
databas
current
host
data
solid
tumor
type
origin
differ
tissu
http
cancergenomenihgov
first
survey
express
tcga
mirseq
data
set
observ
variabl
level
express
across
differ
tumor
cohort
skcm
highest
median
level
figur
next
want
investig
impact
global
gene
express
clinic
outcom
differ
tcga
cohort
end
categor
matur
express
level
cancer
type
divid
patient
cohort
top
bottom
third
previous
done
skcm
perform
differenti
express
analysi
use
publicli
avail
rnaseq
data
examin
common
differenti
gene
express
among
tcga
data
set
calcul
frequenc
gene
significantli
upregul
subset
tcga
cohort
analysi
gene
found
differenti
express
subset
tcga
cancer
analyz
frequenc
differenti
express
would
wherea
gene
significantli
upregul
half
tcga
cancer
frequenc
would
use
approach
summar
frequenc
differenti
upregul
select
immun
gene
patient
subset
figur
expect
express
host
gene
elev
patient
subset
matur
form
higher
figur
interestingli
ptprc
gene
found
upregul
tcga
tumor
cohort
furthermor
gene
encod
cell
signal
transduc
coreceptor
lck
upregul
time
within
cancer
across
tcga
data
set
figur
supplement
figur
transcript
level
cell
effector
gene
ifng
gzmb
tnf
also
elev
least
tumor
note
multipl
gene
encod
canon
marker
immun
cell
subset
nk
cell
itgam
macrophag
granulocyt
itgax
dc
macrophag
also
upregul
cancer
subset
figur
examin
function
pathway
tumor
subset
perform
gsea
use
gene
ontolog
go
hallmark
gene
set
molecular
signatur
databas
msigdb
high
express
correl
strong
enrich
adapt
innat
immun
pathway
solid
tumor
analyz
regardless
origin
figur
supplement
figur
observ
demonstr
express
defin
multicellular
immuneenrich
phenotyp
wide
varieti
human
solid
tumor
analyz
immun
landscap
multidimension
point
view
perform
pca
gene
annot
immun
process
go
term
use
rnaseq
data
tcga
solid
tumor
even
though
tumor
rnaseq
data
analysi
origin
sever
differ
tissu
type
high
express
design
tumor
common
immun
signatur
distinctli
counterpart
evidenc
spatial
separ
data
point
pca
plot
figur
trend
observ
pca
perform
immuneassoci
gene
download
immport
databas
supplement
figur
b
surprisingli
gene
rnaseq
data
set
use
pca
high
express
defin
distinct
tumor
popul
figur
suggest
express
correl
consist
immun
gene
signatur
rather
describ
differ
global
gene
express
pattern
human
solid
tumor
surprisingli
level
express
found
correl
posit
score
report
ock
et
al
ref
across
tcga
solid
tumor
mirror
find
melanoma
supplement
figur
support
role
defin
common
immun
involv
human
cancer
lastli
want
investig
relationship
express
tme
surviv
outcom
human
cancer
univari
cox
proport
hazard
model
use
investig
correl
express
patient
surviv
data
tcga
solid
tumor
cohort
analysi
exclud
tcga
tumor
type
consist
fewer
patient
ii
tumor
consist
timedepend
declin
patient
surviv
lack
see
figur
supplement
figur
tumor
cohort
includ
analysi
result
surviv
analysi
reveal
although
express
variabl
relationship
surviv
depend
tumor
context
invers
correl
hazard
ratio
hr
cox
surviv
model
figur
supplement
tabl
analys
hr
larger
indic
poorer
surviv
ie
increas
hazard
hr
smaller
indic
improv
surviv
ie
decreas
hazard
protect
skcm
hr
valu
correspond
decreas
clinic
hazard
patient
subset
figur
interestingli
mutat
burden
tcga
tumor
analyz
observ
cancer
correl
favor
clinic
outcom
hr
tend
higher
mutat
load
figur
redcolor
data
point
among
tcga
cohort
skcm
exhibit
highest
mutat
burden
follow
lung
squamou
cell
carcinoma
lusc
case
express
correl
improv
prognosi
summari
express
defin
immuneenrich
subtyp
human
cancer
may
impact
tumor
prognosi
although
ultim
surviv
outcom
determin
contribut
tumorspecif
factor
mutat
burden
composit
tme
studi
describ
molecular
characterist
antitumor
immun
respons
mediat
cellspecif
cellular
resolut
via
scseq
technolog
analysi
differ
time
point
reveal
distinct
activ
state
tumorinfiltr
immun
cell
delin
dynam
interact
cell
within
tme
support
previou
literatur
loss
cell
detriment
antitumor
cell
respons
importantli
cellspecif
express
also
critic
shape
intratumor
myeloid
immun
compart
term
cellular
composit
activ
state
although
role
antitumor
immun
evid
earli
tumor
develop
day
import
pronounc
later
time
point
day
suggest
continu
evolut
antitumor
immun
respons
analysi
tcga
data
human
melanoma
reveal
express
correl
immuneenrich
subtyp
associ
improv
clinic
outcom
furthermor
analysi
tcga
data
reveal
express
mark
immuneenrich
phenotyp
solid
tumor
type
although
express
alway
correl
improv
clinic
outcom
tcga
tumor
overal
express
level
found
invers
relationship
clinic
hr
univari
surviv
analysi
find
corrobor
role
promot
antitumor
immun
suggest
marker
immun
enrich
human
cancer
extens
studi
context
inflamm
carcinogenesi
express
induc
immun
cell
upon
stimul
cancer
cell
variou
origin
frequent
overexpress
tumorintrins
shown
tumorpromot
tumorsuppress
function
although
larg
contribut
inflammatori
respons
varieti
immun
cell
type
also
promot
function
regulatori
cell
import
neg
regul
immun
respons
therefor
express
within
tme
variabl
effect
cancer
prognosi
depend
cell
express
find
howev
suggest
higher
express
tumor
correl
improv
surviv
human
cancer
patient
backdrop
renew
interest
mir
therapeut
character
cell
within
tme
critic
reveal
popul
domin
target
therapeut
purpos
previou
studi
report
induc
cell
upon
activ
support
observ
scseq
data
studi
reveal
signific
level
express
activ
cell
cluster
constitut
greater
tumorinfiltr
immun
cell
wt
host
day
tumor
growth
delet
specif
cell
result
lower
level
activ
cell
higher
level
myeloid
cell
tme
indic
invers
relationship
tumorinfiltr
cell
myeloid
cell
subset
interestingli
gene
express
landscap
human
tumor
examin
myeloid
cellspecif
gene
frequent
coexpress
within
tumor
subset
suggest
broad
infiltr
multipl
immun
cell
type
may
explain
induct
activ
multipl
cell
type
tme
inde
express
varieti
immun
cell
activ
cell
includ
macrophag
dc
nk
cell
b
cell
interestingli
shown
convert
immunosuppress
tumorassoci
dc
immunostimulatori
phenotyp
ovarian
cancer
model
suggest
axi
function
immun
cell
tme
albeit
smaller
proport
detect
express
nk
cell
subset
dc
macrophag
support
previou
find
howev
due
low
sequenc
coverag
scseq
cell
express
low
level
may
present
data
set
remain
detect
limit
similarli
unabl
detect
appreci
level
express
myeloid
popul
marker
commonli
use
conjunct
defin
mdsc
although
tumor
shown
rich
mdsc
immunomodulatori
marker
commonli
observ
mdsc
express
consider
portion
cell
data
set
consist
presenc
mdsc
murin
melanoma
tme
find
suggest
deeper
sequenc
coverag
may
need
detect
gene
low
transcript
count
scseq
experi
underscor
import
analyz
multipl
paramet
defin
ident
activ
state
cell
tme
scseq
technolog
increasingli
util
tumor
immun
studi
provid
unpreced
insight
dynam
tumorinfiltr
immun
cell
identifi
sever
distinct
myeloid
lymphoid
cell
cluster
studi
demonstr
distinct
activ
state
immun
cell
murin
melanoma
tme
close
relat
cluster
identifi
scseq
multidimension
analysi
gene
express
would
otherwis
character
cell
type
via
routin
immunophenotyp
method
flow
cytometri
emphas
import
highthroughput
analys
character
cellular
heterogen
within
tme
scseq
studi
also
enabl
us
assess
express
level
target
individu
cell
describ
gene
consist
derepress
activ
cell
upon
loss
differ
time
point
therefor
data
set
serv
resourc
survey
known
novel
target
context
evolv
antitumor
immun
respons
addit
describ
inept
cell
phenotyp
studi
reveal
increas
level
pdc
multipl
subset
neutrophil
macrophag
tcko
mice
cell
type
suggest
promot
tumor
immunoevas
variou
experiment
set
investig
context
antitumor
immun
find
suggest
express
may
gener
marker
immun
infiltr
human
cancer
howev
sinc
express
tumor
cell
immun
cell
tme
elucid
cellular
origin
transcript
bulk
rnaseq
challeng
deconvolut
approach
aim
distinguish
gene
signatur
cancer
immun
cell
rnaseq
data
potenti
employ
address
issu
reveal
detail
immunobiolog
characterist
low
tumor
data
show
strong
posit
correl
express
level
variou
immuneassoci
gene
suggest
transcript
bulk
tumor
rnaseq
origin
immun
compon
support
result
pca
reveal
consist
immun
gene
signatur
within
tumor
subset
result
gsea
show
signific
enrich
sever
inflammatori
pathway
upon
high
express
moreov
tumor
subset
character
predomin
immun
cell
infiltr
histolog
level
skcm
observ
similar
trend
molecular
histolog
analys
tumor
subset
intrigu
gene
express
profil
requir
extract
rna
consider
size
tumor
tissu
histolog
prepar
sampl
micromet
tumor
despit
caveat
subsampl
histolog
assess
immun
infiltr
common
clinic
practic
human
melanoma
studi
reveal
posit
correl
intratumor
lymphocyt
level
clinic
prognosi
find
suggest
enhanc
immun
signatur
mark
higher
express
alway
correl
improv
clinic
outcom
across
tcga
data
set
suggest
tumorspecif
featur
play
import
role
shape
antitumor
immun
respons
tumor
prognosi
two
tumor
type
tcga
data
set
express
associ
better
clinic
outcom
skcm
lusc
character
highest
mutat
burden
among
tcga
cohort
high
genom
instabl
mutat
burden
thought
gener
neoantigen
contribut
tumor
immunogen
support
notion
find
studi
previou
multivari
analys
tcga
data
reveal
tumor
mutat
burden
correl
immun
infiltr
overal
clinic
outcom
determin
contribut
factor
includ
natur
tumor
antigen
characterist
immun
pathway
involv
central
tenet
cancer
immunotherapi
enhanc
immun
cell
infiltr
tumor
also
reprogram
intratumor
immun
landscap
effect
tumor
kill
mark
immuneenrich
subtyp
human
cancer
express
may
identifi
patient
like
benefit
immunotherapi
reprogram
tme
tumor
elimin
inde
express
within
tcga
tumor
exhibit
remark
correl
previous
calcul
immun
score
strongli
predict
clinic
respons
immunotherapi
support
role
immunotherapeut
respons
find
preclin
cancer
model
reveal
although
effect
loss
larg
rescu
immun
checkpoint
blockad
therapi
optim
respons
immunotherapi
requir
function
axi
therefor
character
dynam
antitumor
immun
identifi
correl
express
clinic
paramet
human
solid
cancer
studi
open
new
avenu
pursuit
therapeut
immunotherapi
mice
mice
describ
previous
achiev
cellspecif
knockout
flox
anim
cross
mice
genet
background
due
doubleposit
phase
thymic
cell
develop
cremedi
excis
flox
occur
helper
cytotox
cell
subset
wt
control
mice
contain
flox
cassett
lack
cre
recombinas
use
five
mice
per
group
use
experi
repeat
least
time
murin
melanoma
cell
atcc
cell
express
chicken
ova
model
antigen
use
tumor
experi
cell
cultur
dmem
supplement
fetal
bovin
serum
penicillinstreptomycin
lglutamin
cell
provid
mingnan
chen
univers
utah
deriv
cell
parent
cell
transfect
ovaexpress
plasmid
select
media
contain
mgml
cell
passag
least
prior
inject
confluent
day
inject
adher
cell
trypsin
wash
time
pb
adjust
cell
per
inject
volum
pb
cell
inject
shave
flank
mice
isofluran
anesthesia
tumor
growth
monitor
throughout
experiment
durat
day
experiment
endpoint
day
follow
tumor
inject
tumor
collect
flow
cytometr
analysi
scseq
respect
sampl
prepar
sequenc
tumor
tissu
dissoci
use
scissor
forcep
incub
ml
accumax
innov
cell
technolog
constant
agit
room
temperatur
minut
tumor
least
mice
pool
togeth
per
group
enzymat
digest
cell
stain
dapi
apcconjug
minut
ice
pb
contain
mm
edta
bsa
live
cell
sort
via
bd
facsaria
cell
sorter
wash
pb
contain
bsa
sampl
process
scseq
via
platform
accord
manufactur
instruct
genom
pairedend
rnaseq
cycl
perform
via
agil
hiseq
nextgener
sequenc
sequenc
read
process
use
genom
cellrang
pipelin
analyz
seurat
r
packag
effect
mitochondri
gene
represent
varianc
uniqu
molecular
identifi
umi
count
regress
data
set
prior
analysi
gene
express
signatur
defin
cell
cluster
analyz
aggreg
sampl
wt
tcko
day
raw
data
scseq
experi
manuscript
found
ncbi
gene
express
omnibu
databas
geo
cell
data
set
cluster
use
findclust
function
seurat
analysi
packag
identifi
cluster
via
share
nearest
neighbor
snn
modular
optimizationbas
algorithm
function
identifi
distinct
cluster
span
lymphoid
myeloid
cell
lineag
note
cell
cluster
larger
cell
cluster
compos
mainli
cell
increas
granular
analysi
manual
separ
cluster
name
accordingli
result
cluster
analyz
throughout
manuscript
biolog
ident
cell
cluster
annot
help
immunecel
score
algorithm
develop
hous
avail
http
lab
pathutaheduoconnellresourceshtm
survey
known
immun
cell
marker
scseq
data
set
immunescor
algorithm
compar
gene
signatur
cell
cluster
studi
publicli
avail
microarray
data
host
immunolog
genom
project
databas
immgen
use
differenti
express
gene
signatur
seurat
immunescor
algorithm
perform
follow
step
immgen
cell
popul
gene
found
immgen
microarray
calcul
ratio
normal
microarray
signal
averag
signal
valu
gene
whole
immgen
data
b
appli
natur
log
transform
ratio
result
posit
number
upregul
gene
neg
number
downregul
gene
immgen
data
set
c
multipli
immgen
logratio
valu
logratio
match
gene
differenti
express
cell
cluster
scseq
dataset
sum
score
gene
yield
aggreg
ident
score
immgen
cell
type
given
scseq
cluster
approach
gene
differenti
upregul
downregul
immgen
scseq
data
set
contribut
immun
ident
score
heavili
posit
number
obtain
logratio
valu
sign
multipli
contrast
gene
invers
regul
immgen
scseq
cluster
immun
ident
score
reduc
method
correl
gene
express
signatur
scseq
cell
cluster
studi
immgen
data
subset
assist
determin
cluster
ident
case
algorithm
unabl
make
clear
call
myeloid
cell
subset
survey
express
known
gene
data
set
perform
differenti
express
analys
close
relat
cell
cluster
approach
allow
us
differenti
subset
neutrophil
macrophag
cell
cluster
upon
name
cluster
seurat
r
packag
use
creat
plot
express
select
gene
gsea
analysi
perform
use
fgsea
r
packag
rank
gene
use
signaltonois
metric
stain
tumorinfiltr
immun
cell
tumor
tissu
mechan
disrupt
incub
minut
room
temperatur
ml
accumax
innov
cell
technolog
follow
incub
cell
filter
nylon
filter
obtain
singlecel
suspens
cell
stain
hank
balanc
salt
solut
hbss
supplement
bsa
mm
edta
use
follow
fluorophoreconjug
antibodi
purchas
biolegend
ebiosciencethermofish
scientif
clone
pacif
blue
clone
apc
clone
clone
pe
clone
clone
pe
dilut
stain
cell
surfac
antigen
ice
minut
cell
wash
analyz
use
bd
lsrfortessa
flow
cytomet
data
analysi
done
use
flowjo
tree
star
graphpad
prism
softwar
categor
express
surviv
analysi
publicli
avail
tcga
data
download
use
tcgabiolink
rtcga
r
packag
readspermillion
mir
count
mirseq
experi
use
categor
express
level
cancer
patient
glioblastoma
tumor
tcgagbm
exclud
analysi
due
lack
mirseq
remain
solid
tumor
cohort
data
primari
tumor
consid
tumor
type
except
cutan
melanoma
tcgaskcm
skcm
metastat
primari
tumor
sampl
analyz
major
sampl
deriv
metastat
tumor
rare
case
primari
metastat
tumor
data
avail
patient
primari
tumor
data
includ
analys
type
tumor
express
categor
topand
bottomthird
quantil
percentil
patient
subpopul
design
base
cutoff
surviv
analysi
perform
use
surviv
survmin
r
packag
surviv
outcom
versu
patient
subpopul
examin
use
kaplanmei
loglikelihood
statist
univari
cox
proport
hazard
model
analysi
tumor
cohort
least
patient
exhibit
gradual
timedepend
declin
surviv
includ
rnaseq
differenti
express
analysi
raw
count
data
patient
subpopul
download
use
tcgabiolink
r
packag
differenti
express
analysi
limma
r
packag
use
test
differenti
gene
express
sampl
use
linear
model
rnaseq
data
normal
via
voom
transform
part
packag
tumor
type
separ
remov
gene
express
low
level
differenti
express
gene
visual
volcano
bar
plot
voomtransform
rnaseq
express
valu
patient
subpopul
rank
use
signaltonois
metric
rank
gene
list
analyz
gene
set
enrich
use
fgsea
r
packag
gene
set
use
analys
deriv
molecular
signatur
databas
msigdb
previous
publish
manuscript
investig
immun
signatur
variou
tumor
context
pca
use
investig
relationship
patient
subpopul
tcga
data
set
limit
analysi
share
gene
tumor
type
either
whole
express
data
set
immunerel
gene
use
pca
analys
list
contain
approxim
immunespecif
gene
download
immport
databas
go
browser
tumor
histolog
assess
immun
infiltr
mirseq
data
tcga
databas
analyz
highest
lowest
tumor
select
histolog
examin
solid
tumor
cohort
h
estain
frozen
tumor
section
assess
immun
infiltr
use
tcga
data
repositori
web
interfac
http
portalgdccancergovrepositori
analysi
biospecimen
id
random
provid
boardcertifi
anatom
pathologist
ahg
blind
express
level
tumor
section
devoid
immun
cell
score
tumor
score
nonbrisk
local
lymphocyt
infiltr
observ
score
given
brisk
widespread
lymphocyt
infiltr
present
across
tumor
tissu
assess
tumor
growth
flow
cytometri
data
perform
use
student
test
wilcoxon
test
use
analyz
gene
express
select
scseq
cluster
report
p
valu
correct
multipl
comparison
holmsidak
method
p
valu
less
equal
consid
statist
signific
throughout
p
p
p
p
p
valu
logrank
test
report
skcm
surviv
graph
tcga
differenti
express
analys
benjaminihochbergcorrect
p
valu
calcul
limma
r
packag
plot
experiment
procedur
handl
mice
perform
accord
univers
utah
institut
anim
care
use
committe
iacuc
regul
approv
protocol
tcga
data
analyz
studi
publicli
avail
via
nation
cancer
institut
genom
data
common
gdc
requir
regul
approv
tbh
hae
coordin
perform
experi
analyz
data
prepar
figur
hae
wrote
manuscript
develop
immun
cell
score
algorithm
hae
ahg
score
lymphocyt
infiltr
tcga
melanoma
sampl
maw
jlr
wz
advis
experi
rmo
design
research
advis
experi
edit
manuscript
